Falko-Güenter Falkner

Title: The Innovations of Falko-Güenter Falkner

Introduction

Falko-Güenter Falkner is a notable inventor based in Orth/Donau, Austria. He has made significant contributions to the field of vaccine formulations, particularly through his innovative patent. His work focuses on enhancing the stability and efficacy of vaccine compositions.

Latest Patents

Falkner holds a patent for "Vaccine formulations and uses thereof." This patent describes a liquid or liquid-frozen composition that includes a modified vaccinia Ankara (MVA) virus or its variants, combined with mannitol as the sole stabilization agent. The formulation is designed to maintain stability at temperatures ranging from 0 to +10°C, as well as in liquid-frozen states between -10°C and -30°C. The MVA can be utilized for various therapeutic applications, including vaccines, gene therapy, virotherapy, immunotherapy, and cancer therapy in mammals, particularly humans. He has 1 patent to his name.

Career Highlights

Throughout his career, Falkner has worked with prominent companies such as Baxter International Inc. and Baxter Healthcare SA. His experience in these organizations has contributed to his expertise in vaccine development and formulation.

Collaborations

Falkner has collaborated with notable colleagues, including Manfred Oberreither and Christa Tauer. These partnerships have likely enriched his research and development efforts in the field of immunology.

Conclusion

Falko-Güenter Falkner's innovative work in vaccine formulations showcases his commitment to advancing medical science. His contributions are vital in the ongoing efforts to improve vaccine stability and efficacy for therapeutic use.